DOT1L and pulmonary fibrosis: Of note, DOT1L depletion in vivo markedly inhibited the protein expression levels of bleomycin-induced pulmonary fibrosis markers (FN, CTGF, α-SMA, Collagen I/III, and MMP2/9; Fig. 4C).